Lili Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lili Zhao has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Zhining Fan
Department of Digestive Endoscopy, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, China
10 shared publications Li Liu
Digestive Endoscopy Department Jiangsu Province Hospital and The First Affiliated Hospital with Nanjing Medical University Nanjing China
9 shared publicationsMin Wang
Department of Digestive Endoscopy, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, 210029 Nanjing, Jiangsu, China
9 shared publicationsXiang Wang
Department of Digestive Endoscopy, Jiangsu Province Hospital and The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China
8 shared publicationsYingtong Chen
Department of Digestive Endoscopy, Jiangsu Province Hospital and The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China
5 shared publicationsKexin He
Department of Digestive Endoscopy, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China
4 shared publications
Latest Publications
- 24 June 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 274 (Pt 2) , 133304
Catalase catalyzed tannic acid-Fe3+ network coating: A theranostic strategy for intestinal barrier restoration
- 24 June 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 274 (Pt 2) , 133304
Catalase catalyzed tannic acid-Fe3+ network coating: A theranostic strategy for intestinal barrier restoration
- Open Access
- 21 May 2024
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 48, 104220
Moxifloxacin promotes two-photon microscopic imaging for discriminating different stages of DSS-induced colitis on mice
- 21 May 2024
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 48, 104220
Open AccessMoxifloxacin promotes two-photon microscopic imaging for discriminating different stages of DSS-induced colitis on mice
- Open Access
- 20 July 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-12
Benign esophageal stricture model construction and mechanism exploration
Esophageal stricture is a debilitating condition that negatively impacts patients' quality of life after undergoing endoscopic mucosal resection (EMR). Despite its significance, this disease remains underexplored due to the lack of a stable animal model. Under direct visualization with choledochoscopy, we retrogradely damaged the esophageal mucosal layer through the gastrostomy to create a rat model of esophageal stricture. The development of histological defects in the mucosal layer was assessed over a 2-week period after model induction. Then the models were evaluated using X-ray barium radiography, Hematoxylin–Eosin, Masson’s trichrome, Sirius red, and Victoria blue staining, multiphoton microscopic imaging. Additionally, the molecular mechanisms of esophageal stricture were explored by conducting RNA transcriptome sequencing, PCR, immunohistochemistry, and immunofluorescence staining. We successfully established fifteen rat models of esophageal stricture by injuring the mucosal layer. In the model group, the mucosal defect initially occurs and subsequently repaired. The epithelium was absent and was plastically remodeled by collagen during the acute inflammatory phase (Day 1), proliferation phase (Day 7), anaphase of proliferation (Day 10), and plastic remodeling phase (Day 14). We observed increased expression of COL1A1, acta2, FGF, IL-1, and TGF-β1 pathway in the model group. We established a highly repeatable rat model of esophageal stricture, and our results suggest that the mucosal defect of the esophagus is a critical factor in esophageal stricture development, rather than damage to the muscularis layer. We identified Atp4b, cyp1a2, and gstk1 as potential targets for treating esophageal stricture, while the TGF-β pathway was found to play an important role in its development.
- 20 July 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-12
Open AccessBenign esophageal stricture model construction and mechanism exploration
Esophageal stricture is a debilitating condition that negatively impacts patients' quality of life after undergoing endoscopic mucosal resection (EMR). Despite its significance, this disease remains underexplored due to the lack of a stable animal model. Under direct visualization with choledochoscopy, we retrogradely damaged the esophageal mucosal layer through the gastrostomy to create a rat model of esophageal stricture. The development of histological defects in the mucosal layer was assessed over a 2-week period after model induction. Then the models were evaluated using X-ray barium radiography, Hematoxylin–Eosin, Masson’s trichrome, Sirius red, and Victoria blue staining, multiphoton microscopic imaging. Additionally, the molecular mechanisms of esophageal stricture were explored by conducting RNA transcriptome sequencing, PCR, immunohistochemistry, and immunofluorescence staining. We successfully established fifteen rat models of esophageal stricture by injuring the mucosal layer. In the model group, the mucosal defect initially occurs and subsequently repaired. The epithelium was absent and was plastically remodeled by collagen during the acute inflammatory phase (Day 1), proliferation phase (Day 7), anaphase of proliferation (Day 10), and plastic remodeling phase (Day 14). We observed increased expression of COL1A1, acta2, FGF, IL-1, and TGF-β1 pathway in the model group. We established a highly repeatable rat model of esophageal stricture, and our results suggest that the mucosal defect of the esophagus is a critical factor in esophageal stricture development, rather than damage to the muscularis layer. We identified Atp4b, cyp1a2, and gstk1 as potential targets for treating esophageal stricture, while the TGF-β pathway was found to play an important role in its development.
- 20 January 2023
- Published by Wiley in Journal of Biophotonics
- Vol. 16 (5) , e202200367
Moxifloxacin as a contrast agent of two‐photon microscopic imaging for detecting colorectal diseases
Since two‐photon microscopy (TPM) can obtain high‐resolution images at cellular and subcellular level and moxifloxacin has multiphoton fluorescence characteristic, our study aimed to explore the feasibility and diagnostic value of moxifloxacin‐assisted TPM in different human colorectal diseases, including low‐grade intraepithelial neoplasia (LGIN), high‐grade intraepithelial neoplasia (HGIN) and cancer tissues. Excitation power for TPM imaging with and without moxifloxacin was (2.74 ± 0.16) mW and (0.28 ± 0.02) mW, respectively (p < 0.05). Whether labeled with moxifloxacin or not, images of normal, LGIN, HGIN and cancer tissues all reached the strongest signal at 30 μm from the mucosa. Normalized fluorescence intensity of TPM images with moxifloxacin was approximately 10 times stronger than that without moxifloxacin. Fluorescence signal was differed significantly in normal, LGIN, HGIN and cancer tissues with or without moxifloxacin (p < 0.05). Besides, moxifloxacin‐assisted TPM could present variant tissue features with different colorectal diseases, such as the crypt opening, glandular structure, adjacent glandular space and fluorescence distribution.
- 20 January 2023
- Published by Wiley in Journal of Biophotonics
- Vol. 16 (5) , e202200367
Moxifloxacin as a contrast agent of two‐photon microscopic imaging for detecting colorectal diseases
Since two‐photon microscopy (TPM) can obtain high‐resolution images at cellular and subcellular level and moxifloxacin has multiphoton fluorescence characteristic, our study aimed to explore the feasibility and diagnostic value of moxifloxacin‐assisted TPM in different human colorectal diseases, including low‐grade intraepithelial neoplasia (LGIN), high‐grade intraepithelial neoplasia (HGIN) and cancer tissues. Excitation power for TPM imaging with and without moxifloxacin was (2.74 ± 0.16) mW and (0.28 ± 0.02) mW, respectively (p < 0.05). Whether labeled with moxifloxacin or not, images of normal, LGIN, HGIN and cancer tissues all reached the strongest signal at 30 μm from the mucosa. Normalized fluorescence intensity of TPM images with moxifloxacin was approximately 10 times stronger than that without moxifloxacin. Fluorescence signal was differed significantly in normal, LGIN, HGIN and cancer tissues with or without moxifloxacin (p < 0.05). Besides, moxifloxacin‐assisted TPM could present variant tissue features with different colorectal diseases, such as the crypt opening, glandular structure, adjacent glandular space and fluorescence distribution.
- Open Access
- 1 December 2019
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 90 (6) , 997
Concerns about the safety and efficacy of hot avulsion as an adjunct to EMR
- 1 December 2019
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 90 (6) , 997
Open AccessConcerns about the safety and efficacy of hot avulsion as an adjunct to EMR
- 2 July 2019
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 34 (12) , 2144-2151
Label‐free multiphoton microscopic imaging as a novel real‐time approach for discriminating colorectal lesions: A preliminary study
Background and Aim: Although various endoscopic technologies have been developed to increase the visual diagnostic accuracy of colorectal precancerosis and early carcinoma, the biopsy‐dependent pathology still remains the golden standard. During routine endoscopy, real‐time optical histological diagnosis is desired. Without fluorescent label, multiphoton microscopy (MPM) imaging directly reveals live cellular morphology and tissue microenvironment based on intrinsic two‐photon excited fluorescence and second harmonic generation signals. Its high‐imaging resolution and performance are comparable with the histopathology. We thus aimed to initially investigate the original features of colorectal diseases under MPM and evaluate its potential for real‐time diagnosis.Methods: Experimental and diagnostic cohorts were designed. Multiphoton images of 40 ex vivo fresh tissues confirmed pathologically of colorectal normal tissues, hyperplastic polyps, adenomas, and adenocarcinomas were collected. Features were recorded to establish diagnostic standards with MPM. For the second cohort with 92 fresh tissues, we distinguished the various colorectal diseases with conclusive MPM features.Results: Through the investigation, the colorectal diseases were presented differences in the crypt opening, gland structure, epithelial cells, and collagen fibers. With the typical features, we preliminarily tested the diagnostic efficiency and found that its sensitivity for distinguishing normal, hyperplastic polyps, adenoma and adenocarcinoma was 88.89%, 76.47%, 83.33%, and 97.92%, while the specificity was 99.32%, 94.00%, 94.92%, and 94.12%, respectively.Conclusion: The real‐time multiphoton microscopic imaging can be effective to identify the colorectal lesions with high resolution. Via integrating with the endoscopes in the future, it could promote precise optical diagnosis in clinics.
- 2 July 2019
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 34 (12) , 2144-2151
Label‐free multiphoton microscopic imaging as a novel real‐time approach for discriminating colorectal lesions: A preliminary study
Background and Aim: Although various endoscopic technologies have been developed to increase the visual diagnostic accuracy of colorectal precancerosis and early carcinoma, the biopsy‐dependent pathology still remains the golden standard. During routine endoscopy, real‐time optical histological diagnosis is desired. Without fluorescent label, multiphoton microscopy (MPM) imaging directly reveals live cellular morphology and tissue microenvironment based on intrinsic two‐photon excited fluorescence and second harmonic generation signals. Its high‐imaging resolution and performance are comparable with the histopathology. We thus aimed to initially investigate the original features of colorectal diseases under MPM and evaluate its potential for real‐time diagnosis.Methods: Experimental and diagnostic cohorts were designed. Multiphoton images of 40 ex vivo fresh tissues confirmed pathologically of colorectal normal tissues, hyperplastic polyps, adenomas, and adenocarcinomas were collected. Features were recorded to establish diagnostic standards with MPM. For the second cohort with 92 fresh tissues, we distinguished the various colorectal diseases with conclusive MPM features.Results: Through the investigation, the colorectal diseases were presented differences in the crypt opening, gland structure, epithelial cells, and collagen fibers. With the typical features, we preliminarily tested the diagnostic efficiency and found that its sensitivity for distinguishing normal, hyperplastic polyps, adenoma and adenocarcinoma was 88.89%, 76.47%, 83.33%, and 97.92%, while the specificity was 99.32%, 94.00%, 94.92%, and 94.12%, respectively.Conclusion: The real‐time multiphoton microscopic imaging can be effective to identify the colorectal lesions with high resolution. Via integrating with the endoscopes in the future, it could promote precise optical diagnosis in clinics.
- 10 April 2019
- Published by Springer Nature in Surgical Endoscopy
- Vol. 34 (1) , 417-428
The retrospective comparison between submucosal tunneling endoscopic resection and endoscopic submucosal excavation for managing esophageal submucosal tumors originating from the muscularis propria layer
Submucosal tunneling endoscopic resection (STER) and endoscopic submucosal excavation (ESE) were recently introduced to cure submucosal tumors (SMTs) originating from the muscularis propria (MP) layer. This study aimed to compare clinical performance and safety of STER and ESE in treating esophageal SMTs originating from the MP layer.
- 10 April 2019
- Published by Springer Nature in Surgical Endoscopy
- Vol. 34 (1) , 417-428
The retrospective comparison between submucosal tunneling endoscopic resection and endoscopic submucosal excavation for managing esophageal submucosal tumors originating from the muscularis propria layer
Submucosal tunneling endoscopic resection (STER) and endoscopic submucosal excavation (ESE) were recently introduced to cure submucosal tumors (SMTs) originating from the muscularis propria (MP) layer. This study aimed to compare clinical performance and safety of STER and ESE in treating esophageal SMTs originating from the MP layer.
- Open Access
- 1 March 2019
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 89 (3) , 645
Submucosal injection materials other than mucosal lift
- 1 March 2019
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 89 (3) , 645
Open AccessSubmucosal injection materials other than mucosal lift
- 11 July 2018
- Published by Wiley in Digestive Endoscopy
- Vol. 30 (6) , 741-749
Thermoresponsive aerification and tissue vacuolization for facilitating endoscopic submucosal resection
Background and Aims: Mucosal lifting and its persistence are critical for maintaining the operational space and preventing perforation in endoscopic operation. Although numerous agents have been investigated, optimization is still required for improving their clinical performance. In the present study, we proposed a novel concept of thermoresponsive aerification and tissue vacuolization for submucosal injection.Methods: Lifting performance and operational condition were first evaluated in porcine stomachs in vitro and rabbits in vivo. Dodecafluoropentane (DDFP) injection dosage, lifting persistency and operational assistance were quantitatively recorded. Gross and histological pathology were also analyzed to identify DDFP acute toxicity and long‐term safety. The endoscopic submucosal dissection (ESD) procedure with DDFP was carried out on pigs in vivo to confirm its operational feasibility, efficacy, and safety.Results: Dodecafluoropentane aerification could achieve better mucosal lift with lower dosage (1% of normal saline dosage). Thermoresponsive DDFP aerification could provide continuous replenishment and longer persistence. Meanwhile, its tissue vacuolization effect significantly facilitated submucosal tissue dissection in in vitro study. Similar performance was verified in vivo. The particular vacuole‐like submucosal structure was seen after DDFP onset, which also promoted reepithelization and wound healing. No tissue damage, gas embolism, biotoxicity, and physicochemical risk were observed.Conclusion: Bioinert DDFP was feasible, efficient, and safe as the novel submucosal lifting candidate.
- 11 July 2018
- Published by Wiley in Digestive Endoscopy
- Vol. 30 (6) , 741-749
Thermoresponsive aerification and tissue vacuolization for facilitating endoscopic submucosal resection
Background and Aims: Mucosal lifting and its persistence are critical for maintaining the operational space and preventing perforation in endoscopic operation. Although numerous agents have been investigated, optimization is still required for improving their clinical performance. In the present study, we proposed a novel concept of thermoresponsive aerification and tissue vacuolization for submucosal injection.Methods: Lifting performance and operational condition were first evaluated in porcine stomachs in vitro and rabbits in vivo. Dodecafluoropentane (DDFP) injection dosage, lifting persistency and operational assistance were quantitatively recorded. Gross and histological pathology were also analyzed to identify DDFP acute toxicity and long‐term safety. The endoscopic submucosal dissection (ESD) procedure with DDFP was carried out on pigs in vivo to confirm its operational feasibility, efficacy, and safety.Results: Dodecafluoropentane aerification could achieve better mucosal lift with lower dosage (1% of normal saline dosage). Thermoresponsive DDFP aerification could provide continuous replenishment and longer persistence. Meanwhile, its tissue vacuolization effect significantly facilitated submucosal tissue dissection in in vitro study. Similar performance was verified in vivo. The particular vacuole‐like submucosal structure was seen after DDFP onset, which also promoted reepithelization and wound healing. No tissue damage, gas embolism, biotoxicity, and physicochemical risk were observed.Conclusion: Bioinert DDFP was feasible, efficient, and safe as the novel submucosal lifting candidate.
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Tu1968 - Label-Free Multiphoton Imaging as a Real-Time Diagnostic Tool for Discriminating Colorectal Diseases
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Tu1968 - Label-Free Multiphoton Imaging as a Real-Time Diagnostic Tool for Discriminating Colorectal Diseases